Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MCW I-PREDICT in aggressive malignancies
NCT05674825Phase 2Recruiting
- Sponsor
- Medical College of Wisconsin
- Start
- Dec 2022
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 2, open-label trial in cancer (6 arms), sponsored by Medical College of Wisconsin. Primary endpoint: Matched treatment at 8 months. Started Dec 2022; status: recruiting.
02
Conditions
cancer
Beyond the preview
Go deeper on NCT05674825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05674825.